Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Deletion of the 5′ abl region in Philadelphia chromosome-positive chronic myeloid leukemia

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Huntly BJP, Reid AG, Bench AJ, Campbell LJ, Telford N, Shepherd P, Szer J, Prince HM, Turner P, Grace C, Nacheva EP & Green AR . Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia. Blood 2001; 98: 1732–1738.

    Article  CAS  Google Scholar 

  2. Kolomietz E, Al-Maghrabi J, Brennan S, Karaskova J, Minkin S, Lipton J & Squire JA . Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood 2001; 97: 3581–3588.

    Article  CAS  Google Scholar 

  3. Calabrese G, Stuppia L, Guanciali Franchi P, Peila R, Morizio E, Liberati AM, Spadano A, Di Lorenzo R, Donti E, Antonucci A & Palka G . Complex translocations of the Ph chromosome and Ph negative CML arise from similar mechanisms, as evidenced by FISH analysis. Cancer Genet Cytogenet 1994; 78: 153–159.

    Article  CAS  Google Scholar 

  4. Dewald GW, Wyatt WA & Silver RT . Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy. Leuk Lymphoma 1999; 34: 481–491.

    Article  CAS  Google Scholar 

  5. Grand F, Kulkarni S, Chase A, Goldman JM, Gordon M & Cross NCP . Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia. Cancer Res 1999; 59: 3870–3874.

    CAS  Google Scholar 

  6. Le Gouill S, Talmant P, Milpied N, Daviet A, Ancelot M, Moreau P, Harousseau JL, Bataille R & Avet-Loiseau H . Fluorescence in situ hybridization on peripheral blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia. J Clin Oncol 2000; 18: 1533–1538.

    Article  CAS  Google Scholar 

  7. Sinclair PB, Nacheva EP, Leversha M, Telford N, Chang J, Reid A, Bench A, Champion K, Huntly B & Green AR . Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood 2000; 95: 738–744.

    CAS  PubMed  Google Scholar 

  8. Herens C, Tassin F, Lemaire V, Beguin Y, Collard E, Lampertz S, Croisiau C, Lecomte M, De Prijk B, Longrée L & Koulischer L . Deletion of the 5′-ABL region: a recurrent anomaly detected by fluorescence in situ hybridization in about 10% of Philadelphia-positive chronic myeloid leukaemia patients. Br J Haematol 2000; 110: 214–216.

    Article  CAS  Google Scholar 

  9. Markovic VD, Bouman D, Bayani J, Al-Maghrabi J, Kamel-Reid S & Squire JA . Lack of BCR/ABL reciprocal fusion in variant Philadelphia chromosome translocations: a use of double fusion signal FISH and spectral karyotyping. Leukemia 2000; 14: 1160.

    Article  Google Scholar 

  10. Mohr B, Bornhauser M, Platzbecker U, Freiberg-Richter J, Naumann R, Prange-Krex G, Mohm J, Kroschinsky F, Ehninger G & Thiede C . Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals. Cancer Genet Cytogenet 2001; 127: 111–117.

    Article  CAS  Google Scholar 

  11. Cohen N, Rozenfeld-Granot G, Hardan I, Brok-Simoni F, Amariglio N, Rechavi G & Trakhtenbrot L . Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene: expression profiling, resistance to interferon therapy, and poor prognosis. Cancer Genet Cytogenet 2001; 128: 114–119.

    Article  CAS  Google Scholar 

  12. Gonzalez FA, Anguita E, Mora A, Asenjo S, Lopez I, Polo M & Villegas A . Deletion of BCR region 3′ in chronic myelogenous leukemia. Cancer Genet Cytogenet 2001; 130: 68–74.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morel, F., Ka, C., Le Bris, MJ. et al. Deletion of the 5′ abl region in Philadelphia chromosome-positive chronic myeloid leukemia. Leukemia 17, 473–474 (2003). https://doi.org/10.1038/sj.leu.2402816

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402816

This article is cited by

Search

Quick links